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meta-analysis
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Abstract
Background: Pulse palpation has been recommended as the first step of screening to detect atrial fibrillation. We aimed
to determine and compare the accuracy of different methods for detecting pulse irregularities caused by atrial fibrillation.
Methods: We systematically searched MEDLINE, EMBASE, CINAHL and LILACS until 16 March 2015. Two reviewers
identified eligible studies, extracted data and appraised quality using the QUADAS-2 instrument. Meta-analysis, using the
bivariate hierarchical random effects method, determined average operating points for sensitivities, specificities, positive
and negative likelihood ratios (PLR, NLR); we constructed summary receiver operating characteristic plots.
Results: Twenty-one studies investigated 39 interventions (n¼ 15,129 pulse assessments) for detecting atrial fibrillation.
Compared to 12-lead electrocardiography (ECG) diagnosed atrial fibrillation, blood pressure monitors (BPMs; seven
interventions) and non-12-lead ECGs (20 interventions) had the greatest accuracy for detecting pulse irregularities
attributable to atrial fibrillation (BPM: sensitivity 0.98 (95% confidence interval (CI) 0.92–1.00), specificity 0.92 (95%
CI 0.88–0.95), PLR 12.1 (95% CI 8.2–17.8) and NLR 0.02 (95% CI 0.00–0.09); non-12-lead ECG: sensitivity 0.91 (95% CI
0.86–0.94), specificity 0.95 (95% CI 0.92–0.97), PLR 20.1 (95% CI 12–33.7), NLR 0.09 (95% CI 0.06–0.14)). There were
similar findings for smartphone applications (six interventions) although these studies were small in size. The sensitivity
and specificity of pulse palpation (six interventions) were 0.92 (95% CI 0.85–0.96) and 0.82 (95% CI 0.76–0.88), respect-
ively (PLR 5.2 (95% CI 3.8–7.2), NLR 0.1 (95% CI 0.05–0.18)).
Conclusions: BPMs and non-12-lead ECG were most accurate for detecting pulse irregularities caused by atrial fibril-
lation; other technologies may therefore be pragmatic alternatives to pulse palpation for the first step of atrial fibrillation
screening.
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Introduction
Atrial ﬁbrillation (AF) has a prevalence that increases
with age.1,2 AF is associated with signiﬁcant morbidity
and mortality, most notably from its associated four to
ﬁvefold increased risk of ischaemic stroke,3 and poses a
signiﬁcant public health burden.4 The SAFE trial was
the largest randomised study of AF screening in pri-
mary care and found this to be an eﬀective method
for increasing AF detection when compared to routine
practice.5,6 Combined with the subsequent provision of
antithrombotic therapy,7,8 screening is likely to reduce
1Division of Primary Care, University of Nottingham, UK
2Division of Epidemiology and Public Health, University of Nottingham,
UK
3Centre for Evidence-Based Medicine, University of Oxford, UK
Corresponding author:
Jaspal S Taggar, Division of Primary Care, University of Nottingham,
Medical School, Queen’s Medical Centre, Nottingham NG7 2UH, UK.
Email: Jaspal.taggar@nottingham.ac.uk
European Journal of Preventive
Cardiology
2016, Vol. 23(12) 1330–1338
! The European Society of
Cardiology 2015
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2047487315611347
ejpc.sagepub.com
thromboembolic complications from AF9 and, conse-
quently, this has been proposed to improve AF.10,11
AF screening is a two-stage process. Firstly, asymp-
tomatic patients with irregular pulses are identiﬁed and
then AF is conﬁrmed or excluded using 12-lead electro-
cardiography (ECG).8,10 The accuracy with which
irregular pulses are caused by AF is important; a high
false positive rate would result in many patients having
unnecessary ECG examinations, whereas a high false
negative rate could mean excessive AF diagnoses are
missed.
The SAFE trial used opportunistic pulse palpation
to identify patients over 65 years of age with an irregu-
lar pulse. Although this approach was found to be
eﬀective, no other methods for identifying irregular
pulses have been tested in trials of AF screening.
Pulse palpation may not be the optimal ‘ﬁrst step’ in
identifying patients with suspected AF and using mod-
iﬁed blood pressure (BP) monitors, pulse oximetry or
non-12-lead ECG devices, for example, could improve
the process of screening.12 Despite pulse palpation
being a cheap method for detecting AF, this results in
high false positive cases of suspected AF and it may be
possible to improve the accuracy of identifying patients
with suspected AF using alternative methods. This sys-
tematic review aimed to provide evidence to underpin
the ﬁrst stage of AF screening by describing and com-
paring the diagnostic accuracies of methods for iden-
tifying patients with irregular pulses caused by AF.
Methods
Search strategy and selection criteria
This study was conducted in accordance with guidelines
and methods for systematic reviews and meta-analyses
of diagnostic tests.13–16 We searched MEDLINE,
EMBASE, Cumulative Index to Nursing and Allied
Health (CINAHL) and Latin American and
Caribbean Health Sciences Information System
(LILACS) in all languages published until 16 March
2015 (Appendix 1). In addition, the reference lists of
national guidelines, review articles and included studies
were hand-searched to identify eligible studies. All ran-
domised trials and observational studies, with the
exclusion of case reports and case series, which
recruited participants 18 years of age, investigated
any method of identifying patients with an irregular
pulse or suspected AF (the index test) and compared
the index test with any ECG interpreted by a competent
professional (the reference standard), involved health-
care professionals identifying patients with an irregular
pulse, and reported suﬃcient data to enable calculation
of diagnostic accuracy were included. Studies that
investigated invasive or echocardiographic methods of
identifying AF were excluded. After the removal of
duplicate records, two reviewers (JT and MJ) independ-
ently screened citations for relevance and reviewed full-
text articles using predetermined eligibility criteria. Any
disagreements were resolved by consensus with a third
reviewer (TC).
Data extraction
Data were independently extracted using a prespeciﬁed
data extraction form by two reviewers (JT and MJ).
Any disagreements were resolved by consensus with a
third reviewer (TC). When studies reported ﬁndings
using multiple thresholds for the same intervention,
only data in which thresholds maximised the sensitivity
of the index test were extracted in order to avoid dupli-
cate inclusion of the same index test. The lead authors
of studies for which there were insuﬃcient data for cal-
culation of diagnostic accuracy were contacted to ascer-
tain missing data; studies were only excluded if no
additional data were identiﬁed or if the authors failed
to respond.
Study quality was appraised using the quality assess-
ment of diagnostic accuracy studies-2 (QUADAS-2)
instrument.15,17 In addition, the studies were graded
using the quality scale reported by Van den Bruel
et al.;18 studies were rated as grade A if they fulﬁlled
all QUADAS-2 criteria. Studies were graded D if there
was no or unclear veriﬁcation of the index test ﬁndings
with the reference standard, or if the index test results
were interpreted unblinded to the results of the refer-
ence test. Studies in which there was an unduly long
time delay between index and reference tests, or the
reference test was not independent of the index test,
or the reference test was interpreted unblinded to the
results of the index test were graded C. The remaining
studies that did not fall into these categories were
graded B.
Statistical analysis
We constructed 2 2 contingency tables to enable cal-
culation of the sensitivity and speciﬁcity of each
method for identifying patients with suspected AF.
Meta-analysis, using the bivariate hierarchical random
eﬀects method, was used to determine the average oper-
ating points for sensitivity and speciﬁcity, and enabled
the construction of summary receiver operating charac-
teristic (SROC) plots with 95% prediction regions. We
also calculated positive and negative likelihood ratios
(PLR and NLR) for each detection method. Unlike
sensitivity and speciﬁcity, likelihood ratios make expli-
cit the impact of the test result on the probability of
disease. To minimise heterogeneity we analysed the
results a priori in groups of each method for identifying
Taggar et al. 1331
an irregular pulse. Subgroup analyses were planned
according to study quality and studies conducted in
primary care providing there were four or more studies
within subgroups. Heterogeneity is presumed in meta-
analyses of diagnostic test studies and the I2 statistic
cannot be reliably used for its assessment.16 We there-
fore described any variation in the outcomes from
included studies and our pooled estimates by visual
inspection of the SROC plots and how close individual
studies lie to the predicted receiver operating character-
istic curve.16 Publication bias was assessed within cate-
gories of method for detecting AF using Deeks’ funnel
plot asymmetry test; a P value less than 0.10 was used
to signify the presence of publication bias. Analyses
were conducted using Stata version 11.0 and Review
Manager 5.2 for quality assessments.
Results
After the removal of duplicate records we identiﬁed
5418 potential citations. From these, 69 were identiﬁed
for detailed evaluation (Figure 1). After full-text
review, 21 studies were included in the ﬁnal analyses
(Appendix 2).9,19–38 Five studies met the selection
criteria, but reported insuﬃcient outcome data and
were excluded (Appendix 3).39–43
Study characteristics
Of the 21 studies included (Appendix 2), there were two
randomised trials,9,30 seven case–control,20,21,26,32–35
two cohort24,38 and 10 cross-sectional19,22,23,25,27–29, 31,36,37
studies. The 21 studies investigated 39 interventions
(n¼ 15,129 pulse assessments), which were categorised
as blood pressure monitors (BPMs) (six studies; seven
interventions),25,28,33,36–38 non-12-lead ECG (10 stu-
dies; 20 interventions),9,19–22,24,25,31,32,35 pulse palpation
(six studies; six interventions)9,25,27,30,32,34 and smart-
phone applications (three studies; six interven-
tions).23,26,29 The ﬁve studies that were excluded due
to insuﬃcient reporting of outcome data investigated
pulse palpation, pulse oximetry, smartphone applica-
tions and single-lead ECG as methods for detecting
AF. Although the majority of studies avoided a case–
controlled design, only four were prospective and seven
studies were conducted in a primary care set-
ting.9,25,27,30,32,34,35 AF prevalence ranged from 5.7%
to 25.4% in studies with a prospective design.9,24,30,38
Contact with 
authors
1 citation
7123 excluded:
- 1824 duplicate records
- 5299 not relevant
69 full-text articles assessed
48 excluded:
- 31 not detection studies
- 3 editorials or reviews
- 9 not relevant to study 
design
- 5 insufficient data
21 studies included in final review
7242 titles or abstracts identified and screened for retrieval
Reference List
4 citations
MEDLINE
3194 citations
LILACS
61 citations
EMBASE
3344 citations
CINAHL
638 citations
Figure 1. Study selection and stratification.
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There was substantial variation in the proportion and/
or prevalence of AF in studies within each category of
detection method.
Five studies excluded participants if they were less
than 65 years of age and for two studies age of inclusion
was 75 years.9,25,27,32–34,38 Six studies included partici-
pants who were 18 years or older.24,28–31,36 Ten studies
excluded patients that had been ﬁtted with pacemakers
and/or implantable deﬁbrillators.22,25,27,28,33,35–38
For the majority of studies, the reference standard
was 12-lead ECG interpreted by at least one trained
physician/cardiologist. One study did not specify the
training of the clinician interpreting reference ECGs.19
Five studies reported other reference stand-
ards;27,29,30,34,38 one study used either 12-lead ECG or
ECGs derived from cardiac telemetry;29 three studies
used single or limb-lead ECG;27,30,34 one study used
ECGs derived from Holter monitors.38
Quality assessment
The methodological quality of included studies using
QUADAS-2 criteria is presented in Figure 2. Study
quality was generally low. Using the additional quality
grading system, we classiﬁed one study as A grade
having met all QUADAS-2 criteria.30 Eleven studies
were graded category C or D.9,19,21–23,27,29,32–34,36
Studies with the lowest methodological quality (D
grade) were classiﬁed as this due to either the interpret-
ation of the reference standard being unclear or at high
risk of bias, or due to the index test being interpreted
unblinded to the results of the reference standard.
Category C studies were graded as such because it
was unclear whether there was an appropriate time
interval between the index test and reference standard.
The remaining nine studies were categorised as grade B
in methodological quality.20,24–26,28,31,35,37,38
Data synthesis
Forest plots for diagnostic accuracies of the four meth-
ods for detecting AF are presented (Appendices 4–7).
BPMs had a pooled sensitivity of 0.98 (95% conﬁdence
interval (CI) 0.92–1) and speciﬁcity of 0.92 (95% CI
0.88–0.95); PLR of 12.1 (95% CI 8.2–17.8) and NLR
of 0.02 (95% CI 0.00–0.09). There were similar diag-
nostic accuracies for studies that investigated smart-
phone applications, sensitivity 0.97 (95% CI 0.95–
0.99), speciﬁcity 0.95 (95% CI 0.88–0.98), PLR 19
(95% CI 8–45), NLR 0.03 (95% CI 0.01–0.05); and
non-12-lead ECGs, sensitivity 0.91 (95% CI 0.86–
0.94), speciﬁcity 0.95 (95% CI 0.92–0.97), PLR 20.1
(95% CI 12–33.7), NLR 0.09 (95% CI 0.06–0.14).
Although pulse palpation had a sensitivity that was
comparable to the other methods for detecting
suspected AF (sensitivity of 0.92; 95% CI 0.85–0.96),
there was a substantially lower speciﬁcity for this
method (speciﬁcity 0.82; 95% CI 0.76–0.88); PLR and
NLR for pulse palpation were 5.2 (95% CI 3.8–7.2) and
0.1 (95% CI 0.05–0.18), respectively.
SROC plots for the methods of detecting AF are
presented in Figure 3. Visual inspection of the plots
conﬁrms the accuracy of pulse palpation was lower
than other methods for detecting AF. There was
substantial variation in outcomes of the studies inves-
tigating non-12-lead ECG from the predicted receiver
operating characteristic curve and suggests the hetero-
geneity among these studies was greatest. In contrast,
the heterogeneity was lowest among studies that inves-
tigated smartphone applications for detecting AF.
There was no evidence of publication bias; Deeks’
funnel test P¼ 0.34, P¼ 0.11, P¼ 0.14 and P¼ 0.27 for
studies investigating BPMs, non-12-lead ECG, smart-
phone applications and pulse palpation, respectively.
There were only suﬃcient studies to perform bivari-
ate subgroup analyses according to study quality for
BPM, non-12-lead ECG and pulse palpation interven-
tions. After the exclusion of studies with the lowest
(D grade) quality, there were no substantial diﬀerences
to the primary ﬁndings. (BPMs: sensitivity 0.96 (95%
CI 0.91–0.98), speciﬁcity 0.93 (95% CI 0.89–0.96);
non-12-lead ECG: sensitivity 0.92 (95% CI 0.86–
0.95), speciﬁcity 0.94 (95% CI 0.91–0.97); pulse palpa-
tion: sensitivity 0.93 (95% CI 0.86–0.97), speciﬁcity
0.81 (95% CI 0.76–0.85).)
Suﬃcient studies to perform bivariate subgroup ana-
lyses for primary care studies were available for pulse
palpation and non-12-lead ECG interventions.
The ﬁndings were similar to our primary analyses,
although the speciﬁcity of non-12-lead ECGs was
slightly lower (non-12-lead ECGs: sensitivity 0.91
(95% CI 0.83–0.95), speciﬁcity 0.89 (95% CI 0.85–
0.92); pulse palpation: all studies were conducted in
primary care and ﬁndings already presented above).
Discussion
This review of 21 studies for methods of detecting
irregular pulses caused by AF found modiﬁed BPMs
and non-12-lead ECG devices had the greatest diagnos-
tic accuracy. Although the sensitivities of all methods
for identifying those with AF were similar, the speciﬁ-
city of pulse palpation was substantially lower, which
gives rise to more false positive test results.
Strengths and limitations
This study is the ﬁrst systematic review and meta-ana-
lysis of interventions for detecting suspected AF. A
strength was the use of a protocol, consistent with
Taggar et al. 1333
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Figure 2. Study quality according to QUADAS-2 criteria.
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guidelines for systematic reviews of diagnostic test stu-
dies. We used a comprehensive search strategy and our
ﬁndings supported the lack of publication bias. It is
therefore likely that we included small studies with
less signiﬁcant ﬁndings. Five studies were excluded
from meta-analyses due to insuﬃcient reporting of out-
come data; outcomes that were reported from these
studies were consistent with our pooled ﬁndings and
the eﬀect of their exclusion is likely to be minimal.
Only four of the 21 included studies were prospective
and there were a number of methodological weaknesses
in most studies, as reﬂected by our assessments of study
quality; only one study was judged to fulﬁl all
QUADAS-2 criteria. Most studies were conducted in
a secondary care setting and there was substantial vari-
ation in the proportion of patients with AF. This limits
the generalisability of our ﬁndings to primary care
populations that AF screening is intended for. As
expected, there was heterogeneity among studies
within all intervention categories and this is likely to
be attributable to diﬀerences in study populations and
design. Variation was greatest for studies investigating
non-12-lead ECG for detecting AF. This may be due to
diﬀerences in detection methods within this category as
non-12-lead ECG interventions included single-lead,
three-lead and reconstructed ECG. Furthermore, dif-
ference in healthcare professionals used to interpret
ECGs is also likely to contribute to the heterogeneity
within this intervention category.
Findings in context of previous research
Guidance recommends pulse palpation as the ﬁrst step
for AF screening.10,11 This method of identifying those
with an irregular pulse was evaluated as part of two
randomised trials in primary care; combined with con-
ﬁrmatory 12-lead ECG for diagnosing AF; these stu-
dies suggest this is an eﬃcacious and cost-eﬀective
approach to screening.9,30 More recently, studies have
tended to evaluate alternative screening technologies.
Our review identiﬁed four methods (non-12-lead
ECG, BPMs, smartphone applications and pulse oxim-
etry) as alternative methods for detecting pulse irregu-
larities, although the latter method was not eligible for
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Figure 3. Summary receiver operating characteristic plots of interventions for the detection of atrial fibrillation.
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inclusion in our analyses. Of all interventions, pulse
palpation had the lowest diagnostic accuracy for detect-
ing pulse irregularities caused by AF, as reﬂected by its
lower speciﬁcity. This could be due to diﬀerences in the
threshold of each method to rule in or out AF; elec-
tronic methods, such as BPMs, use software algorithms
to determine the severity of pulse irregularity and only
those patients meeting a predetermined cut-oﬀ point
are classiﬁed as having AF. In contrast, studies inves-
tigating pulse palpation required clinicians to classify
the pulse as being regular or irregular. It is therefore
conceivable that pulse palpation could result in greater
false positive cases of suspected AF due to patients with
transient pulse irregularities (e.g. ventricular extra-sys-
toles) being referred for ECG testing, which software
algorithms would have excluded.
Although pulse palpation is considered a cheap and
feasible method for detecting patients with an irregular
pulse,12 our review highlights the potential for alterna-
tive technologies to improve the identiﬁcation of
those with suspected AF. Any method of detecting
pulse irregularities caused by AF should, in addition
to being cheap, be quick, simple and accurate for it to
be a cost-eﬀective intervention in primary care. Recent
guidance from the National Institute for Health and
Care Excellence (NICE) advocates the use of auto-
mated BPMs for the detection of suspected AF in
patients being screened or monitored for hyperten-
sion.44 We found BPMs to have a substantially greater
accuracy for detecting pulse irregularities caused by AF
than pulse palpation; such devices are likely to be prag-
matic alternatives to pulse palpation as blood pressure
checks are an integral component of existing cardiovas-
cular screening programmes in primary care.45
Furthermore, automated devices would enable screen-
ing to be conducted by all healthcare professionals
without the need for additional training. However, to
date there have been no economic analyses comparing
BPMs to pulse palpation for detecting suspected AF
and this would help to inform optimal planning and
service conﬁgurations of any future AF screening
programme.
Our review highlights the potential of smartphone
applications for detecting suspected AF. This method
had a similar diagnostic accuracy as BPMs. However,
only three studies investigated this detection modality;
two of these investigated multiple software algorithms
in the same cohort of patients and all studies were small
in sample size. This is likely to inﬂate our estimates of
diagnostic accuracy for smartphone applications, and
our ﬁndings should be interpreted with caution.
However, if these ﬁndings are replicated in larger stu-
dies that represent those targeted by screening, this
raises the possibility of using such technologies within
both the clinic and home settings.
The second stage of AF screening is diagnosing AF
in patients with an irregular pulse. The gold standard
test for diagnosing AF is 12-lead ECG interpreted by a
competent professional.8,11 The range and accuracies of
methods for diagnosing AF using 12-lead ECG is not
known. Indeed, optimising the accuracy of both stages
to AF screening will help ensure the eﬀectiveness of this
intervention and planning of appropriate service con-
ﬁguration for delivering screening.
Conclusion
BPMs and non-12-lead ECG devices had a greater
accuracy for detecting pulse irregularities caused by
AF than pulse palpation. Newer technologies may
therefore be a pragmatic alternative to pulse palpation
for identifying patients with suspected AF as part of
national screening programmes.
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